William M C Rosenberg

Summary

Affiliation: University of Southampton
Country: UK

Publications

  1. ncbi Success in treating mild chronic hepatitis C: different outcomes -- new guidelines?
    William M C Rosenberg
    University of Southampton, Southampton General Hospital, Southampton, UK
    Eur J Gastroenterol Hepatol 14:595-7. 2002
  2. ncbi Variation in hepatitis C services may lead to inequity of heath-care provision: a survey of the organisation and delivery of services in the United Kingdom
    Julie Parkes
    Public Health Sciences and Medical Statistics 805 Level C, University of Southampton, Southampton General Hospital, Tremona Road, Southampton UK
    BMC Public Health 6:3. 2006
  3. ncbi Development of a decision support tool to facilitate primary care management of patients with abnormal liver function tests without clinically apparent liver disease [HTA03/38/02]. Abnormal Liver Function Investigations Evaluation (ALFIE)
    Peter T Donnan
    Tayside Centre for General Practice, Community Health Sciences, University of Dundee, Dundee, UK
    BMC Health Serv Res 7:54. 2007
  4. ncbi Serum markers detect the presence of liver fibrosis: a cohort study
    William M C Rosenberg
    Liver Group, Division of Infection, Inflammation and Repair, University of Southampton, England SO16 6YD
    Gastroenterology 127:1704-13. 2004
  5. ncbi HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection
    Salim I Khakoo
    Liver Group, Division of Infection, Inflammation, and Repair, Southampton University, Southampton 5016 6YD, UK
    Science 305:872-4. 2004
  6. ncbi Renal hepatitis C in the absence of detectable serum or hepatic virus
    Andrew J Fowell
    Liver Research Group, Division of Infection, Inflammation and Repair, Southampton General Hospital, University of Southampton, Southampton, UK
    Liver Int 28:889-91. 2008
  7. ncbi Rating fibrosis progression in chronic liver diseases
    William M C Rosenberg
    J Hepatol 38:357-60. 2003

Collaborators

Detail Information

Publications7

  1. ncbi Success in treating mild chronic hepatitis C: different outcomes -- new guidelines?
    William M C Rosenberg
    University of Southampton, Southampton General Hospital, Southampton, UK
    Eur J Gastroenterol Hepatol 14:595-7. 2002
    ....
  2. ncbi Variation in hepatitis C services may lead to inequity of heath-care provision: a survey of the organisation and delivery of services in the United Kingdom
    Julie Parkes
    Public Health Sciences and Medical Statistics 805 Level C, University of Southampton, Southampton General Hospital, Tremona Road, Southampton UK
    BMC Public Health 6:3. 2006
    ..There is a need to determine patterns of healthcare delivery to plan improvements. A study was conducted to determine workload, configuration and care processes of current UK services available to manage patients with CHC...
  3. ncbi Development of a decision support tool to facilitate primary care management of patients with abnormal liver function tests without clinically apparent liver disease [HTA03/38/02]. Abnormal Liver Function Investigations Evaluation (ALFIE)
    Peter T Donnan
    Tayside Centre for General Practice, Community Health Sciences, University of Dundee, Dundee, UK
    BMC Health Serv Res 7:54. 2007
    ....
  4. ncbi Serum markers detect the presence of liver fibrosis: a cohort study
    William M C Rosenberg
    Liver Group, Division of Infection, Inflammation and Repair, University of Southampton, England SO16 6YD
    Gastroenterology 127:1704-13. 2004
    ..We developed a panel of sensitive automated immunoassays to detect matrix constituents and mediators of matrix remodeling in serum to evaluate their performance in the detection of liver fibrosis...
  5. ncbi HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection
    Salim I Khakoo
    Liver Group, Division of Infection, Inflammation, and Repair, Southampton University, Southampton 5016 6YD, UK
    Science 305:872-4. 2004
    ..The data strongly suggest that inhibitory NK cell interactions are important in determining antiviral immunity and that diminished inhibitory responses confer protection against HCV...
  6. ncbi Renal hepatitis C in the absence of detectable serum or hepatic virus
    Andrew J Fowell
    Liver Research Group, Division of Infection, Inflammation and Repair, Southampton General Hospital, University of Southampton, Southampton, UK
    Liver Int 28:889-91. 2008
    ..The implications of this finding are discussed, with particular reference to current concepts regarding 'occult' hepatitis C infection...
  7. ncbi Rating fibrosis progression in chronic liver diseases
    William M C Rosenberg
    J Hepatol 38:357-60. 2003